• FirefoxInstall the new Firefox »
  •  Dow Up 0.59% Nasdaq Up 0.63%

    Vertex Pharmaceuticals Incorporated (VRTX)

    -NasdaqGS
    119.95 Up 0.52(0.44%) 10:17AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:119.43
    Open:120.62
    Bid:119.84 x 200
    Ask:120.00 x 200
    1y Target Est:134.50
    Beta:-0.7
    Earnings Date:Apr 29 - May 4 (Est.)
    Day's Range:119.32 - 120.68
    52wk Range:59.79 - 127.69
    Volume:327,271
    Avg Vol (3m):1,606,160
    Market Cap:29.04B
    P/E (ttm):N/A
    EPS (ttm):-3.14
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    VRTXUp 0.44%29.04B
    BMYUp 1.58%102.85B
    MRKUp 0.38%166.77B
    PTCTDown 0.21%2.34B

    Key Statistics

    Forward P/E (1 yr):30.61
    P/S (ttm):49.81
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.58
    Quarterly EPS Est (Mar-15) :-0.74
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):-2.53

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Vertex Pharmaceuticals Incorporated engages in discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback